Janux Therapeutics, Inc. Insider Transactions
Janux Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 29,474 @ $50.61 | $1.49 M | 2,731,817 | 10/16/2024 | 10/18/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 11,657 @ $49.69 | $579,236 | 534,883 | 10/16/2024 | 10/18/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 5,710 @ $50.61 | $288,983 | 529,173 | 10/16/2024 | 10/18/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 10,957 @ $50.80 | $556,616 | 6,445 | 10/16/2024 | 10/18/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 958 @ $46.24 | $44,298 | 6,887 | 09/30/2024 | 09/30/2024 | |
| Sell | 50,000 @ $45.96 | $2.30 M | 67,592 | 09/27/2024 | 09/27/2024 | ||
|
DiRaimondo Thomas
Chief Scientific Officer |
Sell | 4,325 @ $46.21 | $199,840 | 98,613 | 09/27/2024 | 09/27/2024 | |
|
DiRaimondo Thomas
Chief Scientific Officer |
Sell | 675 @ $47.22 | $31,877 | 97,938 | 09/27/2024 | 09/27/2024 | |
| Sell | 18,957 @ $46.09 | $873,715 | 313,097 | 09/27/2024 | 09/27/2024 | ||
| Sell | 5,248 @ $46.86 | $245,895 | 307,849 | 09/27/2024 | 09/27/2024 | ||
| Sell | 795 @ $47.84 | $38,032 | 307,054 | 09/27/2024 | 09/27/2024 | ||
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 46,861 @ $46.42 | $2.18 M | 2,882,353 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,542 @ $47.74 | $73,615 | 2,880,811 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 45,894 @ $46.42 | $2.13 M | 2,822,981 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,511 @ $47.74 | $72,135 | 2,821,470 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 8,894 @ $46.42 | $412,859 | 546,833 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 293 @ $47.74 | $13,988 | 546,540 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 1,826 @ $46.19 | $84,343 | 6,926 | 09/27/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 50,539 @ $46.78 | $2.36 M | 2,970,875 | 09/26/2024 | 09/30/2024 | |
|
Avalon Ventures XI, L.P.
10 percent owner |
Sell | 41,661 @ $47.77 | $1.99 M | 2,929,214 | 09/26/2024 | 09/30/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Janux Therapeutics, Inc. FAQ's
The list of insiders at Janux Therapeutics, Inc. includes Avalon Ventures XI, L.P., Reardon Tighe, Lichter Jay, Campbell David Alan, DiRaimondo Thomas, Meyer Andrew Hollman, RA CAPITAL MANAGEMENT, L.P..
Insiders have sold a total of 6.67 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 341.45 M sold.
The following insiders have sold Janux Therapeutics, Inc. shares in the last 12 months: Avalon Ventures XI, L.P. ($205.38 M), Reardon Tighe ($45.04 M), Lichter Jay ($82.30 M), Campbell David Alan ($6.20 M), DiRaimondo Thomas ($231,716), Meyer Andrew Hollman ($2.30 M),
Insiders have purchased a total of 1.20 M Janux Therapeutics, Inc. shares in the last 12 months for a total of 53.70 M.
The following insiders have purchased Janux Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($53.70 M),